AbbVie Inc., US00287Y1091

AbbVie stock heads into the open after a 2.99 percent drop

Published on 09/09/2026 at 06:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 8, 2026, AbbVie stock fell 2.99 percent to USD 248.78. The move came with the S&P 500 down 0.58 percent to 7,673.52, and AbbVie is due for a session shaped by inflation data and pre-open market tone.

Fotorealistisches Pharma-Forschungslabor mit Petrischalen und Wissenschaftlern in Schutzkleidung
AbbVie Inc. US00287Y1091 fotorealistisches Pharma Forschungslabor mit Petrischalen Wissenschaftlern Immunologie Onkologie Biopharma, Illustration mit AI erstellt.

AbbVie stock closed at USD 248.78 on the Nasdaq on September 8, 2026, down 2.99 percent from the prior session. The move came as the S&P 500 fell 0.58 percent to 7,673.52, and AbbVie outperformed the broader benchmark by 2.41 percentage points.

September 8, 2026 in numbers

AbbVie Inc. (ISIN US00287Y1091, NYSE: ABBV) traded between USD 248.41 and USD 256.46 during the session, with volume at 5,139,733 shares. The close sat 6.99 percent below the 52-week high of USD 267.47 and 30.4 percent above the 52-week low of USD 190.75.

MarketBeat cited the company's last quarterly results from July 31, 2026, and noted that AbbVie had set Q3 2026 guidance at EPS 3.840 to 3.880. That guidance frame remained the most relevant dated company backdrop in the market chatter around the share move.

Today before the open

Today brings Yahoo Finance economic-calendar entries for September 9, 2026, including the U.S. inflation release set for the session. Those macro figures can influence healthcare shares through the rate outlook and broader risk appetite.

Disclaimer...

en | US00287Y1091 | ABBVIE INC. | boerse | 70072545 | bgmi